Showing results (301-310 of 519) with videos related to

Sort By:
Pageof 52
Carcinogenesis|July 1, 1993
Roles of different forms of cytochrome P450 in the activation of the promutagen 6-aminochrysene to genotoxic metabolites in human liver microsomesH Yamazaki, M Mimura, Y Oda, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|January 12, 2000
[Characterization of voltage-independent Ca2+ channels activated by endothelin-1]Y Iwamuro, X F Zhang, Y Okamoto, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|January 12, 2000
[Analysis of Ca2+ entry channels in endothelin-1-induced contraction of rat aorta using new blockers]X F Zhang, Y Iwamuro, Y Okamoto, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1981
Use of cultured lymphoblastoid cells for the study of abnormal enzymes: molecular abnormality of a phosphoglycerate kinase variant associated with hemolytic anemiaH Fujii, S H Chen, J Akatsuka, et al.
The Journal of Biological Chemistry|September 12, 1997
SUG1, a component of the 26 S proteasome, is an ATPase stimulated by specific RNAsY Makino, K Yamano, M Kanemaki, et al.
Chemical & Pharmaceutical Bulletin|June 1, 1996
Agents for the treatment of overactive detrusor. IX. Synthesis and pharmacological properties of metabolites of N-tert-Butyl-4,4-diphenyl-2-cyclopentenylamine (FK584) in human urineK Taniguchi, Y Miyao, K Yamano, et al.
Oncogene|August 6, 1998
Transforming growth factor-beta1-induced degradation of activated Src tyrosine kinase in rat fibroblastsK Fukuda, S Kawata, S Tamura, et al.
Hepatology (Baltimore, Md.)|September 10, 1998
Altered regulation of Src tyrosine kinase by transforming growth factor beta1 in a human hepatoma cell lineK Fukuda, S Kawata, S Tamura, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 14, 1997
High concentration of glucose increases mitogenic responsiveness to heparin-binding epidermal growth factor-like growth factor in rat vascular smooth muscle cellsK Fukuda, S Kawata, Y Inui, et al.
International Journal of Cancer|March 1, 1996
Inhibition of cell growth of human hepatoma cell line (Hep G2) by a farnesyl protein transferase inhibitor: a preferential suppression of ras farnesylationT Nagase, S Kawata, S Tamura, et al.
Pageof 52